Synthonics' Unattributed - III Round

Synthonics raised a round of funding on July 28, 2014.

Synthonics is a specialty pharmaceutical company focused on the discovery, development and licensing of drugs that incorporate our proprietary metal coordination chemistry. Metal coordination entails …

Articles about Synthonics' Unattributed - III Round: